Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Clinical trial NCT00122382 · COMPLETED

Trial details

NCT number: NCT00122382
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2005-07-01
Primary completion: 2008-02-01
Enrollment: 1052

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.